Items where Author is "Symonds, P"

Journal article

COOK, K., XUE, W., SYMONDS, P., DANIELS, I., GIJON, M., BOOCOCK, D., COVENEY, C., MILES, A., SHAH, S., ATABANI, S., CHOUDHURY, R., VAGHELA, P., WESTON, D., METHERINGHAM, R., BRENTVILLE, V. and DURRANT, L., 2021. Homocitrullination of lysine residues mediated by myeloid derived suppressor cells in the tumour environment is a target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer, 9 (7): e001910.

Other

BRENTVILLE, V.A., VANKEMMELBEKE, M., METHINGHAM, R.L., SYMONDS, P., COOK, K.W., URBANOWICZ, R.A., TSOLERIDIS, T., COLEMAN, C.M., CHANG, K.-C., SKINNER, A., DUBININA, E., DANIELS, I., POCKLEY, A.G., SHAH, S., DIXON, J.E., ADAMS, S.E., PASTON, S.J., DALY, J.M., BALL, J.K. and DURRANT, L.G., 2021. A novel bivalent DNA vaccine encoding both spike protein receptor-binding domain and nucleocapsid protein of SARS-CoV-2 to elicit T cell and neutralising antibody responses that cross react with variants. Cold Spring Harbor Laboratory. (Submitted)